Ceiling Prices Of 915 Formulations Fixed: Govt

New Delhi : The government on Tuesday said that till July 17, ceiling prices have been fixed for 915 scheduled formulations. Out of the total, ceiling prices of 691 formulations have been fixed under the National List of Essential Medicines (NLEM) 2022 and 224 formulations under NLEM 2015, Union Minister of State for Chemicals and Fertilisers Bhagwanth Khuba said in a written reply to Rajya Sabha.

Besides, the retail price of around 2,450 new drugs under Drugs (Prices Control) Order, 2013 has been fixed till July 7, 2023, he noted.

The minister also stated that a total of 5,772 complaints alleging overcharging were received by drug pricing regulatory body NPPA over the five-year period ranging between 2018-19 and 2022-23.

Replying to a query regarding the Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs), Khuba said 9,512 outlets are now functional across the country.

The product basket of PMBJP presently comprises about 1,800 medicines and 285 surgical devices, covering all major therapeutic groups, he noted.

The government has fixed a target for opening 10,000 PMBJKs by March 2024.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?